Edison Partners has led a $9 million Series C financing round for Clinverse, a provider of automated financial management solutions for clinical trials. Clinverse's platform automates payments, budgeting, forecasting, contract management, accruals, accounting and reporting, accelerating clinical trials and reducing workload throughout the clinical trial financial life-cycle. The company has now raised over $17 million of funding. Its previous largest round was a 2012 $3.8 million Series B that garnered a valuation of $13 million. The new capital will accelerate Clinverse's product roadmap, bolster infrastructure and expand sales and marketing. Edison, which invested $5 million in the round, was joined by Hatteras Venture Partners.